Polyphor AG’s License Agreement With Fosun Pharma For Balixafortide In China

Paolo Bossi Europe, Europe Legal Chronicle

VISCHER advised Polyphor AG on all legal issues related to the transaction. Polyphor AG (SIX: POLN) and Shanghai Fosun Pharmaceutical (Group) Co. Ltd (“Fosun Pharma”, stock…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Paolo Bossi

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here